Back to top
more

Cronos Group (CRON)

(Real Time Quote from BATS)

$2.27 USD

2.27
1,424,799

-0.05 (-2.16%)

Updated Aug 9, 2024 09:40 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (97 out of 250)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Benjamin Rains headshot

Is Constellation Brands (STZ) Stock a Buy Heading into Q2 Earnings?

by Benjamin Rains

Should investors consider buying shares of Constellation Brands (STZ) as we head into the release of its second quarter fiscal 2020 earnings results, due out on Thursday, October 3?

Indrajit Bandyopadhyay headshot

Epidolex Progresses: Will the Marijuana Drug Market Boom?

by Indrajit Bandyopadhyay

Cannabis (or marijuana) based medical products have the potential to become the next booming industry.

GW Pharma Gets EU Nod for Anti-Epileptic Drug Epidyolex

by Zacks Equity Research

GW Pharmaceuticals (GWPH) wins EU approval for Epidyolex as an adjunctive treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in patients aged two years and above.

Nilanjan Gupta headshot

Cannabis Industry to Scale New Highs Amid Legalization Woes

by Nilanjan Gupta

Legalization will likely drive commercial distribution of cannabis and boost growth of companies operating in this space.

Can Altria Battle Dwindling Cigarette Sales & Vaping Worries?

by Zacks Equity Research

Altria (MO) is reeling under regulatory pressures in the tobacco industry. However, higher pricing is likely to provide support.

Cronos Group (CRON) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Cronos Group (CRON) closed the most recent trading day at $10.96, moving -1.7% from the previous trading session.

Benjamin Rains headshot

Buy Aurora Cannabis (ACB) Stock Before Earnings, Despite Marijuana Volatility?

by Benjamin Rains

Despite growing sales and wider legalization, many pot stocks have been insanely volatile as Wall Street and investors try to wrap their heads around the marijuana industry. So should you think about buying "cheap" Aurora Cannabis (ACB) Stock before Q4 earnings?

Altria (MO) in Talks to Unite With Philip Morris, Stock Down

by Zacks Equity Research

Altria (MO) is in discussions with Philip Morris to consider the prospects of a merger. The companies have not revealed further information regarding the development.

Mitchell Moore headshot

Altria and Phillip Morris International in Merger Talks: What you Need to Know

by Mitchell Moore

On Tuesday, tobacco giants Altria (MO) and Philip Morris International (PM) announced discussions of a possible merger. The two companies stated that a deal has not yet been reached, but that it is possible and talks are underway.

Daniel Laboe headshot

Canopy Growth (CGC) Earnings After The Bell: How High Can They Go?

by Daniel Laboe

Canopy is the clear leader in the marijuana space with a vastly diversified portfolio of cannabis products along with its STZ partnership.

Sanghamitra Saha headshot

ETFs in Focus as Consolidation Drives Marijuana Industry

by Sanghamitra Saha

Deals activity has been robust in the marijuana space, paving way for gains in these cannabis ETFs.

Has Cronos Group (CRON) Outpaced Other Finance Stocks This Year?

by Zacks Equity Research

Is (CRON) Outperforming Other Finance Stocks This Year?

Cronos Group (CRON) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Cronos (CRON) delivered earnings and revenue surprises of 50.00% and 35.62%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Cronos (CRON) to Report Q2 Earnings: What's in the Cards?

by Zacks Equity Research

Investors will focus on Cronos' (CRON) regular top and bottom-line numbers along with its pipeline progress when it reports second-quarter results.

Cronos Group (CRON) Stock Moves -0.79%: What You Should Know

by Zacks Equity Research

Cronos Group (CRON) closed the most recent trading day at $13.81, moving -0.79% from the previous trading session.

Neena Mishra headshot

Marijuana & Blockchain ETFs: Should You Buy?

by Neena Mishra

Cannabis and blockchain are high-risk, high-reward areas of the market. Should investors consider these ETFs?

Mitchell Moore headshot

What to Expect from Altria Earnings as MO Stock Continues to Struggle

by Mitchell Moore

Altria Group (MO) stock is up just 1.5% so far in 2019 to lag behind the tobacco market's nearly 16% climb. Let's see if we should expect this underperformance to continue following the release of Altria's earnings report before the market opens on Tuesday, July 30, or might MO shares get a boost.

Cronos Group (CRON) Gains But Lags Market: What You Should Know

by Zacks Equity Research

Cronos Group (CRON) closed at $15.43 in the latest trading session, marking a +0.39% move from the prior day.

Smokeless Unit & Pricing to Boost Altria's (MO) Q2 Earnings

by Zacks Equity Research

Altria's (MO) Q2 performance is likely to gain from RRPs, high pricing and saving initiatives.

Zacks Market Edge Highlights: MJ, YOLO, THCX, TLRY and CRON

by Zacks Equity Research

Zacks Market Edge Highlights: MJ, YOLO, THCX, TLRY and CRON

Cronos Group (CRON) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Cronos Group (CRON) closed at $14.99 in the latest trading session, marking a +0.33% move from the prior day.

Tracey Ryniec headshot

Should You Buy a Cannabis ETF?

by Tracey Ryniec

There are now 3 pot ETFs with several more to launch soon. Is this a good way for investors to get exposure to the cannabis industry?

Cronos to Acquire Apotex's Manufacturing Plant in Winnipeg

by Zacks Equity Research

Cronos (CRON) inks deal to acquire fermentation and manufacturing facility in Winnipeg, Canada, from Apotex Fermentation Inc.

Cronos Group (CRON) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Cronos Group (CRON) closed the most recent trading day at $15.29, moving -1.55% from the previous trading session.

CannTrust Falls as Health Canada Issues Non-Compliance Report

by Zacks Equity Research

Health Canada issues a non-compliance report on CannTrust (CTST) regarding its greenhouse facility in Pelham, Ontario, which is used for growing cannabis. Shares take a hit.